The National Institute for Health and Care Excellence

Our first guideline on kidney cancer recommends better use of biopsies to avoid surgery

The NICE guideline recommends offering a biopsy to help confirm the diagnosis and inform treatment options for people with suspected renal cell carcinoma (RCC), where the cancer has not spread (known ...
The National Institute for Health and Care Excellence

Hundreds of people set to benefit after life-extending lung cancer treatment given green light

Targeted immunotherapy found to significantly increase overall survival rates for people with an aggressive form of lung cancer has been recommended by NICE. People with an aggressive form of lung ...
National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Pneumonia: diagnosis and management QS110 19 January 2016 2 September 2025 Pneumonia: diagnosis and management NG250 2 September 2025 2 September 2025 Suspected acute respiratory infection in over 16s ...
National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Chronic heart failure in adults: diagnosis and management NG106 12 September 2018 3 September 2025 ...
National Institute for Health and Care Excellence

Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer

There is a commercial access agreement for pembrolizumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact [email protected] ...
National Institute for Health and Care Excellence

Medicines management

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.